Literature DB >> 23090026

Angiogenesis: A deeper understanding of VEGFR inhibitors.

Charlotte Harrison.   

Abstract

Entities:  

Year:  2012        PMID： 23090026     DOI： 10.1038/nrc3390

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors.

Authors:  Michele McTigue; Brion William Murray; Jeffrey H Chen; Ya-Li Deng; James Solowiej; Robert S Kania
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205
  1 in total
  3 in total

Review 1.  Autophagy as a mechanism for anti-angiogenic therapy resistance.

Authors:  Ankush Chandra; Jonathan Rick; Garima Yagnik; Manish K Aghi
Journal:  Semin Cancer Biol       Date:  2019-08-28       Impact factor: 15.707

2.  Inhibition of Transglutaminase 2 but Not of MDM2 Has a Significant Therapeutic Effect on Renal Cell Carcinoma.

Authors:  Joon Hee Kang; Seon-Hyeong Lee; Jae-Seon Lee; Su-Jin Oh; Ji Sun Ha; Hyun-Jung Choi; Soo-Youl Kim
Journal:  Cells       Date:  2020-06-16       Impact factor: 6.600

Review 3.  A Precision Strategy to Cure Renal Cell Carcinoma by Targeting Transglutaminase 2.

Authors:  Soo-Youl Kim; Jeffrey W Keillor
Journal:  Int J Mol Sci       Date:  2020-04-03       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.